Ru Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Extracellular vesicles in disease
Papers in
-
- RNA modifications and cancer 24
- Epigenetics and DNA Methylation 11
- Circular RNAs in diseases 10
- Cancer-related gene regulation 9
- RNA Research and Splicing 7
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 9
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- Jianjun He (4 shared papers)Yayun Zhu (4 shared papers)Xiaoqin Liao (2 shared papers)Ligang Niu (1 shared paper)Xiaoxu Liu (1 shared paper)Dandan Yi (7 shared papers)Jianfeng Sang (7 shared papers)Hongzhi Ma (21 shared papers)
- Journals
- Scientific Reports (4 papers)Tumor Biology (3 papers)European Archives of Oto-Rhino-Laryngology (3 papers)Frontiers in Immunology (2 papers)Oncology Reports (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Ru Wang
138 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 635
- Molecular Biology 1.3k
- Oncology 408
- Aging 19
- Pulmonary and Respiratory Medicine 283
Countries citing papers authored by Ru Wang
This map shows the geographic impact of Ru Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Wang more than expected).
Fields of papers citing papers by Ru Wang
This network shows the impact of papers produced by Ru Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Wang. The network helps show where Ru Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ru Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer Hit paper breakdown → | 2019 | 279 |
| 2 | 2020 | 93 | |
| 3 | 2020 | 86 | |
| 4 | 2019 | 75 | |
| 5 | 2021 | 61 | |
| 6 | 2013 | 55 | |
| 7 | 2017 | 54 | |
| 8 | 2016 | 49 | |
| 9 | 2004 | 47 | |
| 10 | 2020 | 45 | |
| 11 | 2021 | 45 | |
| 12 | 2011 | 43 | |
| 13 | 2022 | 43 | |
| 14 | 2018 | 43 | |
| 15 | 2024 | 42 | |
| 16 | 2021 | 37 | |
| 17 | 2017 | 37 | |
| 18 | 2013 | 35 | |
| 19 | 2019 | 32 | |
| 20 | 2019 | 32 |
About Ru Wang
Ru Wang is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Immunology, having authored 151 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (24 papers), Epigenetics and DNA Methylation (11 papers), Circular RNAs in diseases (10 papers), Cancer-related gene regulation (9 papers), MicroRNA in disease regulation (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (635 citations), Molecular Biology (1.3k citations), Oncology (408 citations), Aging (19 citations) and Pulmonary and Respiratory Medicine (283 citations). Ru Wang has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Jianjun He, Yayun Zhu, Xiaoqin Liao, Ligang Niu, Xiaoxu Liu, Dandan Yi, Jianfeng Sang, Hongzhi Ma, Meng Lian and Xianbiao Shi. Their work appears in journals such as Scientific Reports, Tumor Biology, European Archives of Oto-Rhino-Laryngology, Frontiers in Immunology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.